Bigfoot Biomedical Annual Revenue, Number of Employees, Growth and Funding

Claim your profile

Overview

Location:
Total Funding:$106.9M
Industry:Medical Equip
Founded:2014
Lead Investor(s):Janus Henderson Investors
Press
Claim your profile

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Bigfoot Biomedical's estimated annual revenue is currently $25.1M per year.
  • Bigfoot Biomedical received $55.0M in venture funding in March 2018.
  • Bigfoot Biomedical's estimated revenue per employee is $251,000
  • Bigfoot Biomedical's total funding is $106.9M.

Employee Data

  • Bigfoot Biomedical has 100 Employees.
  • Bigfoot Biomedical grew their employee count by -24% last year.
  • Bigfoot Biomedical currently has 1 job openings.

Executive Contacts

NameTitle
Jeremy RossSenior Manager Of Model-based Design
Suman DattaDirector of Commercial
Max GillVice President Market Access & Reimbursement
Andrew BochenkoSenior Product Manager
Lesli DesimoneDirector of Clinical Research Programs
Yongbo WangSenior Manager
Geoffrey ShipsidesGeneral Counsel
Steve GreenDirector Of Information Security
Nitya NarayananDirector of Regulatory Affairs
Lee BuiDirector, Quality Engineering

Bigfoot Biomedical is a new kind of medical device company developing technologies to significantly reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes. With an intense focus on ease of use, Bigfoot will optimize the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. The company's pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. Bigfoot will be the first company to deliver a monthly subscription-based service leveraging a smart, connected insulin dosing platform to meet the needs of a diverse population with insulin-requiring diabetes. Bigfoot's investigational system is comprised of best-in-class proprietary and licensed components holistically and securely integrated, leveraging intuitive design, machine learning, and a mobile app running on an off-the-shelf smartphone, all designed to keep glucose levels in an optimal range. The net result is a company that brings something unique to the table: a remarkable depth of knowledge and technical know-how combined with the personal motivation and direct patient experience necessary to really make a difference in this space. ---The MedTech Strategist, October 24, 2016

keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals

100

Number of Employees

$25.1M

Revenue (est)

1

Current Jobs

-24%

Employee Growth %

$106.9M

Total Funding

N/A

Valuation

N/A

Accelerator

B2C

Type

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Caldera Medical
$25.6M10211%N/A
JenaValve Techn...
$11.5M4644%N/A
Anatomage
$22.6M902%N/A
Neural Analytic...
$22.6M90-23%N/A
Semler Scientif...
$17.6M7027%N/A
Bigfoot Biomedi...
$25.1M100-24%N/A
Enlitic
$10.8M4343%N/A
Intersect ENT
$100.7M40116%N/A
Centro Medico D...
$21.3M859%N/A
WHILL
$16.8M673%N/A

Bigfoot Biomedical News

09/03/2019 - Artificial Pancreas Devices Systems Market By Major Players ...

Artificial Pancreas Devices Systems Market By Major Players Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes ...

09/08/2019 - Artificial Pancreas Device Systems Market Impressive Gains including key players: Medtronic, Bigfoot Biomedical, Beta Bionics

Some of the key players operating in this market include: Medtronic, Bigfoot Biomedical, Beta Bionics. Development policies and plans are ...

09/03/2019 - Insulin Pump Sensor Market Competition Situation Research Report from 2019-2025 | Animas, BD, Bigfoot Biomedical

Animas, BD, Bigfoot Biomedical, Boston Scientific, CCS Medical, Dexcom, Eli Lilly, Gluco-Chaser, GluSense, GlySens, Insulet, Medtronic.

Bigfoot Biomedical Funding

DateAmountRoundLead InvestorsReference
2015-05-14$3.5MUndisclosedArticle
2015-07-29$3.8MUndisclosedArticle
2015-08-25$6.5MUndisclosedArticle
2016-01-29$2.4MUndisclosedArticle
2016-10-10$12.0MAMultipleArticle
2017-12-19$37.0MUndisclosedJanus Henderson InvestorsArticle
2018-03-29$55.0MBArticle

Bigfoot Biomedical Executive Hires

DateNameTitleReference
2018-10-22Ian HansonChief Technology OfficerArticle